Publications by authors named "Femke Verwer"

Claim this Profile
I
Improved Outcome for ALL by Prolonging Therapy for Deletion and Decreasing Therapy for Other Risk Groups.
Rob Pieters, Hester de Groot-Kruseman, Marta Fiocco, Femke Verwer, Merian Van Overveld

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study.
Marius Flasinski, Kira Scheibke, Martin Zimmermann, Ursula Creutzig, Katarina Reinhardt, Femke Verwer

Blood Adv· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-based -ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML.
David G J Cucchi, Barbara Denys, Gertjan J L Kaspers, Jeroen J W M Janssen, Gert J Ossenkoppele, Femke Verwer

Blood· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis